Trials / Completed
CompletedNCT00080496
Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Tigecycline Vs Imipenem/Cilastatin For The Treatment Of Subjects With Nosocomial Pneumonia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 430 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy and safety of the tigecycline regimen with that of the imipenem/cilastatin regimen in subjects with nosocomial pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tigecycline | |
| DRUG | Imipenem | |
| DRUG | Cilastatin |
Timeline
- Start date
- 2003-07-01
- Completion
- 2006-12-01
- First posted
- 2004-04-07
- Last updated
- 2008-08-04
Locations
29 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00080496. Inclusion in this directory is not an endorsement.